Parents' willingness to pay for their children's COVID-19 vaccine in Taiwan, China: A cross-sectional study

Hum Vaccin Immunother. 2023 Dec 31;19(1):2168936. doi: 10.1080/21645515.2023.2168936. Epub 2023 Jan 22.

Abstract

Most COVID-19 studies aim to assess factors influencing willingness to pay for vaccines between the public and medical staff. However, few studies focus on parents' willingness to pay for their children's COVID-19 vaccine. The current study aimed to assess parents' willingness to pay for their children's vaccination against COVID-19 and its influencing factors. This population-based cross-sectional study used a self-administered questionnaire. The inclusion criterion was parents with at least one child younger than 18 years. The final analysis included 384 valid data points. A total of 89.1% of the parents indicated that they are willing to pay for their children's vaccination against COVID-19. Among them, both fathers' and mothers' willingness to pay for their children's COVID-19 vaccine was 89.6%. The mean and median willingness to pay were% would pay for their children. Excluding other confounding factors, willingness to pay for the COVID-19 vaccine for themselves and hesitation to vaccinate their children were significantly associated with parents' willingness to pay for their children's COVID-19 vaccine. We found that 89.1% of the parents in Taiwan would pay for their children's COVID-19 vaccine. Parents' willingness to pay for themselves and hesitation to vaccinate their children were associated with willingness to pay. Reducing hesitation about vaccines and developing policies for vaccine payment may have a positive impact on willingness to pay for vaccines and promoting COVID-19 vaccination.

Keywords: COVID-19 vaccine; China; Taiwan; Willingness to pay; children; parents.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19 Vaccines*
  • COVID-19* / prevention & control
  • Child
  • China
  • Cross-Sectional Studies
  • Female
  • Humans
  • Parents
  • Taiwan
  • Vaccination

Substances

  • COVID-19 Vaccines

Grants and funding

This study was supported in part by the Medical and Health Science and Technology Project of Zhejiang Province (2020385612) and Science and Technology Administration Public Interest Technology Research Project of Zhejiang Province (LGF19H030013).